D. S. DEDE Et Al. , "Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherary," JOURNAL OF BUON , vol.18, no.2, pp.366-371, 2013
DEDE, D. S. Et Al. 2013. Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherary. JOURNAL OF BUON , vol.18, no.2 , 366-371.
DEDE, D. S., GUMUSKAYA, B., Guler, G., ONAT, D., ALTUNDAG, K., & ÖZIŞIK, Y. Y., (2013). Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherary. JOURNAL OF BUON , vol.18, no.2, 366-371.
DEDE, D. Et Al. "Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherary," JOURNAL OF BUON , vol.18, no.2, 366-371, 2013
DEDE, D. S. Et Al. "Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherary." JOURNAL OF BUON , vol.18, no.2, pp.366-371, 2013
DEDE, D. S. Et Al. (2013) . "Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherary." JOURNAL OF BUON , vol.18, no.2, pp.366-371.
@article{article, author={D. S. DEDE Et Al. }, title={Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherary}, journal={JOURNAL OF BUON}, year=2013, pages={366-371} }